I don't see data lock in the 'bold red' section Senti pointed out. If it's related to the trial,
completion of any randomized clinical trial that meets its endpoint(s)
would indicate they have top line data. With data lock, they are still blinded. To meet endpoints, one would have to have the data unblinded, i.e. here the stats from IDMC.
I don't know what to think of this though. There is the 'board discretion' joker which can come into play. Then again, it's so close to actual data lock and the initial plan (end of June/Beginning of July) for TLD, that one could imagine the very best. I am not getting overly excited at this point.
I'll wait for the PR.
Best of luck with your investments!